AGA2115

· Angitia Incorporated Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AGA2115, covering 2025-01-10 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN) [Phase 2]